The 10-day moving average for NURE crossed bullishly above the 50-day moving average on October 22, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 17 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 89%.
The Stochastic Oscillator is in the oversold zone. Keep an eye out for a move up in the foreseeable future.
NURE moved above its 50-day moving average on October 16, 2026 date and that indicates a change from a downward trend to an upward trend.
Following a +0.74% 3-day Advance, the price is estimated to grow further. Considering data from situations where NURE advanced for three days, in 245 of 306 cases, the price rose further within the following month. The odds of a continued upward trend are 80%.
The Aroon Indicator entered an Uptrend today. In 180 of 253 cases where NURE Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 71%.
The 10-day RSI Indicator for NURE moved out of overbought territory on November 05, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 26 similar instances where the indicator moved out of overbought territory. In 22 of the 26 cases, the stock moved lower in the following days. This puts the odds of a move lower at 85%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on NURE as a result. In 63 of 84 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 75%.
The Moving Average Convergence Divergence Histogram (MACD) for NURE turned negative on November 16, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 47 similar instances when the indicator turned negative. In 36 of the 47 cases the stock turned lower in the days that followed. This puts the odds of success at 77%.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where NURE declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 84%.
NURE broke above its upper Bollinger Band on November 04, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator for VMRK moved out of overbought territory on November 12, 2026. This could be a bearish sign for the stock and investors may want to consider selling or taking a defensive position. A.I.dvisor looked at 62 similar instances where the indicator exited the overbought zone. In 44 of the 62 cases the stock moved lower. This puts the odds of a downward move at 71%.
The 10-day RSI Indicator for VMRK moved out of overbought territory on November 11, 2026. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 28 similar instances where the indicator moved out of overbought territory. In 18 of the 28 cases, the stock moved lower in the following days. This puts the odds of a move lower at 64%.
The Momentum Indicator moved below the 0 level on November 18, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VMRK as a result. In 58 of 96 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 60%.
The Moving Average Convergence Divergence Histogram (MACD) for VMRK turned negative on November 18, 2026. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 44 similar instances when the indicator turned negative. In 30 of the 44 cases the stock turned lower in the days that followed. This puts the odds of success at 68%.
The 50-day moving average for VMRK moved below the 200-day moving average on October 22, 2026. This could be a long-term bearish signal for the stock as the stock shifts to an downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where VMRK declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 56%.
VMRK broke above its upper Bollinger Band on November 05, 2026. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
VMRK moved above its 50-day moving average on November 04, 2026 date and that indicates a change from a downward trend to an upward trend.
The 10-day moving average for VMRK crossed bullishly above the 50-day moving average on November 04, 2026. This indicates that the trend has shifted higher and could be considered a buy signal. In 5 of 19 past instances when the 10-day crossed above the 50-day, the stock continued to move higher over the following month. The odds of a continued upward trend are 26%.
Following a +1.28% 3-day Advance, the price is estimated to grow further. Considering data from situations where VMRK advanced for three days, in 148 of 309 cases, the price rose further within the following month. The odds of a continued upward trend are 48%.
The Aroon Indicator entered an Uptrend today. In 95 of 232 cases where VMRK Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are 41%.
The Tickeron Price Growth Rating for this company is 47 (best 1 - 100 worst), indicating steady price growth. VMRK’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is 54 (best 1 - 100 worst), pointing to consistent earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The Tickeron SMR rating for this company is 75 (best 1 - 100 worst), indicating slightly better than average sales and a considerably profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Valuation Rating of 95 (best 1 - 100 worst) indicates that the company is significantly overvalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: VMRK's P/B Ratio (4.216) is slightly higher than the industry average of (2.264). P/E Ratio (25.133) is within average values for comparable stocks, (17.966). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (6.621). Dividend Yield (0.043) settles around the average of (0.240) among similar stocks. VMRK's P/S Ratio (8.104) is slightly higher than the industry average of (5.580).
The Tickeron Profit vs. Risk Rating rating for this company is 100 (best 1 - 100 worst), indicating that the returns do not compensate for the risks. VMRK’s unstable profits reported over time resulted in significant Drawdowns within these last five years. A stable profit reduces stock drawdown and volatility. The average Profit vs. Risk Rating rating for the industry is 95, placing this stock worse than average.
VMRK | ||
|---|---|---|
OUTLOOK RATING 1..100 | 31 | |
VALUATION overvalued / fair valued / undervalued 1..100 | 95 Overvalued | |
PROFIT vs RISK RATING 1..100 | 100 | |
SMR RATING 1..100 | 75 | |
PRICE GROWTH RATING 1..100 | 47 | |
P/E GROWTH RATING 1..100 | 54 | |
SEASONALITY SCORE 1..100 | n/a |
Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.
| NURE | VMRK | |
|---|---|---|
| RSI ODDS (%) | 2 days ago 85% | 2 days ago 64% |
| Stochastic ODDS (%) | 2 days ago 75% | 2 days ago 71% |
| Momentum ODDS (%) | 2 days ago 75% | 2 days ago 60% |
| MACD ODDS (%) | 2 days ago 77% | 2 days ago 68% |
| TrendWeek ODDS (%) | 2 days ago 81% | 2 days ago 58% |
| TrendMonth ODDS (%) | 2 days ago 80% | 2 days ago 49% |
| Advances ODDS (%) | 4 days ago 80% | 4 days ago 48% |
| Declines ODDS (%) | 8 days ago 84% | 2 days ago 56% |
| BollingerBands ODDS (%) | 2 days ago 74% | 2 days ago 56% |
| Aroon ODDS (%) | 2 days ago 71% | 2 days ago 41% |
A.I.dvisor indicates that over the last year, NURE has been closely correlated with UDR. These tickers have moved in lockstep 83% of the time. This A.I.-generated data suggests there is a high statistical probability that if NURE jumps, then UDR could also see price increases.
| Ticker / NAME | Correlation To NURE | 1D Price Change % | ||
|---|---|---|---|---|
| NURE | 100% | +0.03% | ||
| UDR - NURE | 83% Closely correlated | +0.03% | ||
| MAA - NURE | 82% Closely correlated | -0.68% | ||
| CPT - NURE | 80% Closely correlated | -0.32% | ||
| ESS - NURE | 76% Closely correlated | +1.06% | ||
| VMRK - NURE | 75% Closely correlated | -0.78% | ||
More | ||||
A.I.dvisor indicates that over the last year, VMRK has been closely correlated with ESS. These tickers have moved in lockstep 82% of the time. This A.I.-generated data suggests there is a high statistical probability that if VMRK jumps, then ESS could also see price increases.
| Ticker / NAME | Correlation To VMRK | 1D Price Change % | ||
|---|---|---|---|---|
| VMRK | 100% | -0.78% | ||
| ESS - VMRK | 82% Closely correlated | +1.06% | ||
| MAA - VMRK | 81% Closely correlated | -0.68% | ||
| UDR - VMRK | 81% Closely correlated | +0.03% | ||
| CPT - VMRK | 79% Closely correlated | -0.32% | ||
| AMH - VMRK | 70% Closely correlated | -0.22% | ||
More | ||||